INDIANAPOLIS, July 14, 2015 /PRNewswire/ --
News Highlights
- Now for Android: Lilly Diabetes' Glucagon Mobile App to support
#diabetes caregivers
- Leverage the power of Android or iPhone technology through the
Lilly Glucagon Mobile App for people with #diabetes
- Help be prepared for a severe #diabetes low blood sugar episode
with the Lilly Glucagon Mobile App for Android or iPhone
Lilly Diabetes has released an Android version of its mobile
application designed for caregivers and healthcare providers who
support people with diabetes. Through an injection tutorial
and emergency instructions, the App can help people practice the
injection steps ahead of time, which may help them feel better
prepared to assist. Other features of the App include a kit
location log, so kits can be easily located during an emergency,
and an expiration date log that sends a reminder when a kit is
getting close to its expiration date, so a new kit can be obtained
before this date.
Glucagon is a treatment for insulin coma or insulin reaction
resulting from severe low blood sugar. Glucagon should not be used
if you have pheochromocytoma or if you are allergic to
Glucagon.
The Lilly Glucagon Mobile App for Android mobile devices is
available as a free download on Google Play TM. It
has been available on the iTunes® store as a free download for
Apple mobile devices since September
2012.
"Lilly Diabetes is committed to developing personalized
solutions to help people with diabetes achieve their treatment
goals and improve their outcomes—including the creation of
innovative online tools that provide a range of support," said
Matt Caffrey, senior director,
consumer marketing, Lilly Diabetes. "The new version of the Lilly
Glucagon Mobile App leverages the power of Android mobile
technology, helping us reach even more caregivers and providing
another opportunity to support people living with type 1
diabetes."
Important Safety Information for Glucagon
What is the most important information I should know
about Glucagon?
- Glucagon should not be used if you have pheochromocytoma or if
you are allergic to Glucagon.
- Make sure you tell your healthcare provider if you have been
diagnosed with or have been suspected of having an insulinoma as
Glucagon should be used cautiously in this situation.
- You and anyone who may need to help you during an emergency
should become familiar with how to use Glucagon before an emergency
arises. Read the Information for the User provided in the kit.
- Make sure that your relatives or close friends know that if you
become unconscious, medical assistance must always be sought. If
you are unconscious, Glucagon can be given while awaiting medical
assistance.
- Do not use the kit after the date stamped on the bottle
label.
- If you have questions concerning the use of this product,
consult a doctor, nurse or pharmacist.
WARNING: YOU MAY BE IN A
COMA FROM SEVERE HYPERGLYCEMIA (HIGH BLOOD GLUCOSE) RATHER THAN
HYPOGLYCEMIA. IN SUCH A CASE, YOU WILL NOT RESPOND TO
GLUCAGON AND REQUIRE IMMEDIATE MEDICAL ATTENTION.
Who should not use Glucagon?
Glucagon should
not be used if you have pheochromocytoma or if you are allergic to
Glucagon.
What should I tell my doctor before taking
Glucagon?
Tell your doctor about all of your medical
conditions and prescription and over-the-counter drugs. Tell
your doctor if you have been diagnosed with or have been suspected
of having pheochromocytoma or an insulinoma.
How should I use Glucagon?
- Act quickly. Prolonged unconsciousness may be harmful.
- Make sure your family and friends know to turn you on your side
to prevent choking if you are unconscious.
- The contents of the syringe are inactive and must be mixed with
the Glucagon in the accompanying bottle immediately before giving
injection. Do not prepare Glucagon for Injection until you are
ready to use it.
- Glucagon should not be used unless the solution is clear and of
a water-like consistency.
- The usual adult dose is 1 mg (1 unit). For children weighing
less than 44 lbs (20 kg), give ½ adult dose (0.5 mg). For children,
withdraw ½ of the solution from the bottle (0.5 mg mark on
syringe). Discard unused portion.
- You should eat as soon as you awaken and are able to swallow.
Inform a doctor or emergency services immediately.
What is some important Information I should know about Low
Blood Sugar (Hypoglycemia)?
- Early symptoms of low blood sugar include: sweating,
drowsiness, dizziness, sleep disturbances, palpitation, anxiety,
tremor, blurred vision, hunger, slurred speech, restlessness,
depressed mood, tingling in the hands, feet, lips, or tongue,
irritability, lightheadedness, abnormal behavior, inability to
concentrate, unsteady movement, headache, and personality changes.
These symptoms may be different for each person and can happen
suddenly.
- If your low blood sugar is not treated, you may progress to
severe low blood sugar that can include: disorientation, seizures,
unconsciousness, and death.
- Low blood sugar symptoms should be treated with a quick source
of sugar which should always be carried with you. If you do not
improve or you are unable to take a quick source of sugar, you
should be treated with Glucagon or with intravenous glucose at a
medical facility.
What are the possible side effects of
Glucagon?
- Severe side effects are very rare, although nausea and vomiting
may occur occasionally.
- A few people may be allergic to Glucagon or to one of the
inactive ingredients in Glucagon, or may experience rapid heart
beat for a short while.
- If you experience any other reactions which are likely to have
been caused by Glucagon, please contact your doctor.
You are encouraged to report negative side effects of
prescription drugs to the FDA. Visit www.fda.gov/medwatch or
call 1-800-FDA-1088.
How should I store Glucagon?
- Before dissolving Glucagon with diluting solution, store the
kit at controlled room temperature between 20° to 25°C (68° to
77°F).
- After dissolving Glucagon with diluting solution, use
immediately. Discard any unused portion. Glucagon should be
clear and of a water-like consistency at time of use.
Glucagon is available by prescription only.
For more safety information, please see Information
for the User and Information for the
Physician.
HI GLUC CON ISI 09OCT2014
About Lilly Diabetes
Lilly has been a global leader in
diabetes care since 1923, when we introduced the world's first
commercial insulin. Today we are building upon this heritage by
working to meet the diverse needs of people with diabetes and those
who care for them. Through research and collaboration, a broad and
growing product portfolio, and a continued determination to provide
real solutions—from medicines to support programs and more—we
strive to make life better for all those affected by diabetes
around the world. For more information, visit www.lillydiabetes.com
and follow @LillyDiabetes on Twitter.
About Eli Lilly and Company (NYSE: LLY)
Lilly is
a global healthcare leader that unites caring with discovery to
make life better for people around the world. We were founded more
than a century ago by a man committed to creating high-quality
medicines that meet real needs, and today we remain true to that
mission in all our work. Across the globe, Lilly employees work to
discover and bring life-changing medicines to those who need them,
improve the understanding and management of disease, and give back
to communities through philanthropy and volunteerism. To learn more
about Lilly, please visit us at www.lilly.com and
newsroom.lilly.com/social-channels.
LD96226 04/2015 ©Lilly USA, LLC
2015. All rights reserved.
P-LLY
Refer to: 317-627-4056; williamsju@lilly.com;
Julie Herrick Williams, Lilly
Diabetes
Google Play TM, a registered trademark of Google,
Inc.
iTunes® is a registered trademark of Apple, Inc.
Logo - http://photos.prnewswire.com/prnh/20031219/LLYLOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/lilly-diabetes-launches-android-version-of-glucagon-mobile-application-for-those-who-support-people-with-diabetes-300113099.html
SOURCE Eli Lilly and Company